Oxacillin Pan

Oxacillin, the active ingredient in Oxacillin Pan, is a beta‑lactam antibiotic presented as a sterile powder for intravenous use. It treats infections caused by susceptible gram‑positive bacteria, particularly in patients requiring hospital‑based therapy.

GNH USA supplies Oxacillin Pan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxacillin is a penicillin‑type antibiotic that acts on bacterial cell‑wall synthesis pathways. It is employed in several clinical situations: - Skin and soft‑tissue infections: helps reduce bacterial load and promote healing. - Bone and joint infections (osteomyelitis, septic arthritis): provides bactericidal activity against Staphylococcus aureus. - Endocarditis prophylaxis and treatment: targets susceptible streptococcal and staphylococcal strains. - Respiratory tract infections: effective against penicillin‑sensitive Streptococcus pneumoniae. - Surgical site prophylaxis: reduces postoperative infection risk.

Adverse reactions to oxacillin may vary in frequency and severity.

Common Side Effects: - Rash: mild erythema or maculopapular eruption. - Diarrhea: loose stools, often self‑limiting. - Nausea: occasional upset stomach. - Elevated liver enzymes: transient increase in ALT/AST. - Injection site pain: discomfort at IV infusion site.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Stevens‑Johnson syndrome: extensive skin detachment. - Hemolytic anemia: destruction of red blood cells. - Nephrotoxicity: impaired kidney function. - Clostridioides difficile infection: severe colitis following dysbiosis.

When using Oxacillin Pan, consider the following safety measures: - Allergy assessment: verify no history of severe penicillin allergy. - Renal function: adjust dosing in patients with impaired kidney function. - Hepatic monitoring: check liver enzymes during prolonged therapy. - Drug‑interaction review: assess concomitant medications that affect renal clearance. - Superinfection vigilance: monitor for signs of fungal or C. difficile overgrowth. Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Oxacillin may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Methotrexate: oxacillin can decrease renal clearance, raising methotrexate levels. - Aminoglycosides: concurrent use may heighten risk of nephrotoxicity.

Moderate Interactions (Monitor Closely): - Warfarin: oxacillin may enhance anticoagulant effect, necessitating INR monitoring. - Oral contraceptives: possible reduction in hormonal efficacy, advise backup contraception. - Probenecid: may increase oxacillin plasma concentrations, requiring dose adjustment.